SFRP1 and Myocardial fibrosis: In general, Sfrp1 overexpression can effectively reduce the degree of myocardial fibrosis in the early stage of AMI, inhibit cardiomyocyte apoptosis, and thus improve post-AMI injury healing and cardiac function in aged mice.